Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort
NCT ID: NCT02506348
Last Updated: 2015-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diclofenac vs Dexamethasone in Combined Surgery
NCT00825864
Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery
NCT07178639
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
NCT03406689
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
NCT00333255
An Evaluation of the Safety and Efficacy of FID 114657
NCT01030237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The results may aid both doctors and patients in decision regarding the post surgical anti-inflammatory treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diclofenac+Nepafenac
one drop Diclofenac in one eye one drop Nepafenac in other eye
Diclofenac
Nepafenac
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diclofenac
Nepafenac
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* cognitive decline
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wolfson Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asaf Achiron
Dr.Asaf Achiron
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The E.Wolfson Medical Center
Holon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Asaf Achiron, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0011-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.